A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency
Phase 3
Completed
- Conditions
- Exocrine Pancreatic InsufficiencySteatorrheaMalabsorption SyndromesCystic Fibrosis
- Interventions
- Drug: Pancrease MT 10.5, or MT 21Drug: Placebo for Pancrease MT 10.5 or MT 21
- First Posted Date
- 2008-04-21
- Last Posted Date
- 2014-05-09
- Target Recruit Count
- 40
- Registration Number
- NCT00662675
CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2010-04-27
- Target Recruit Count
- 220
- Registration Number
- NCT00653952
A Study of the Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have Diabetes
- First Posted Date
- 2008-04-02
- Last Posted Date
- 2013-05-24
- Target Recruit Count
- 376
- Registration Number
- NCT00650806
A 52-week, Open-label Extension Study Following a 6-week, Double-blind, Placebo- and Active- Controlled Study (R076477-SCH-303) to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-04-02
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 473
- Registration Number
- NCT00650793
A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors.
- First Posted Date
- 2008-04-02
- Last Posted Date
- 2013-03-08
- Target Recruit Count
- 14
- Registration Number
- NCT00651365
Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.
Phase 1
Completed
- Conditions
- SchizophreniaSchizoaffective Disorders
- First Posted Date
- 2008-03-27
- Last Posted Date
- 2010-04-26
- Target Recruit Count
- 40
- Registration Number
- NCT00645502
A Study to Evaluate the Pharmacokinetics and Safety of Levofloxacin in Patients With Varying Degrees of Renal Function.
Phase 1
Completed
- Conditions
- Renal Diseases
- First Posted Date
- 2008-03-27
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 59
- Registration Number
- NCT00645437
A 52 Week Open Label Extension Trial Following the Recurrence Prevention Study R076477-SCH-301 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia.
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-03-27
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 235
- Registration Number
- NCT00645307
An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes
Phase 2
Completed
- Conditions
- Diabetes Mellitus, Type IIDiabetes Mellitus, Non Insulin Dependent
- Interventions
- First Posted Date
- 2008-03-25
- Last Posted Date
- 2013-07-19
- Target Recruit Count
- 451
- Registration Number
- NCT00642278
A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease
Phase 1
Completed
- Conditions
- AnemiaChronic Kidney Disease
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 40
- Registration Number
- NCT00641589
© Copyright 2025. All Rights Reserved by MedPath